Use a stepwise approach when selecting treatment for cutaneous sarcoidosis

    loading  Checking for direct PDF access through Ovid

Abstract

Treatment of cutaneous sarcoidosis is associated with substantial improvements in the condition in clinical practice; however, robust clinical trial data regarding the efficacy of various treatments are lacking. Topical agents should be considered first-line options in all patients, with the addition of systemic immunomodulators and/or immunosuppressants if required.

Related Topics

    loading  Loading Related Articles